HCW Biologics Inc. (HCWB) stock
HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)
Close on Nov 18, 2026Market cap $1.40MP/E –Yield –
HCW Biologics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
HCW Biologics's enterprise value was $6.50M on Nov 11, 2026, against $9.00M a year earlier. Over the last 5 years it ranged from -$16.52M to $70.69M, with a median of $17.81M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $6.50M | -9.9% |
| 2025 | Dec 31, 2025 | $7.22M | -67.1% |
| 2024 | Dec 31, 2024 | $21.94M | -33.2% |
| 2023 | Dec 29, 2023 | $32.87M | -22.3% |
| 2022 | Dec 30, 2022 | $42.31M | – |
| 2021 | Dec 31, 2021 | -$14.53M | – |
See a number that looks wrong?